Swiss biotech startup ALP Bio has secured €161,000 from Venture Kick to develop a platform combining human immune tissue models and AI to predict immune-related risks in biologic drug development, improving safety and success rates.
Airway Shield, a Spanish startup developing a medical device to make endotracheal intubation safer, has launched a funding round to raise 800,000 euros. The company has already secured 320,000 euros in commitments.
Quibim, a Spanish AI medical imaging company, has launched QP-Breast in Europe and the UK, the first AI tool for detecting breast cancer via MRI after obtaining regulatory approvals. The tool accurately identifies suspicious lesions and generates detailed reports.
Ysios Capital, a leading European venture capital firm in life sciences, announced the divestment of Memo Therapeutics AG following its acquisition by global biopharmaceutical company Ipsen. The deal includes an initial payment of 200 million euros.
Romanian private healthcare provider MedLife announced the opening of a new hyperclinic in Bucharest, Romania, following a 1 million EUR investment. The facility integrates laboratory tests, specialist consultations, and functional monitoring, expanding MedLife’s network to 37 hyperclinics nationwide.
Doktor.se, a digital and physical healthcare provider, has secured a 1.5 billion SEK loan from Swedbank. CEO Martin Lindman describes the loan as a ‘quality stamp’ for the company.
Telum Therapeutics, a biotech company leveraging metagenomic datasets, synthetic biology, and generative AI to develop novel antimicrobial therapies, announced the closure of an 18 million euro Series A round. The funding will advance its primary program for hospital-acquired bacterial pneumonia.
Epitome Therapeutics, an Austrian BioTech startup focused on precision epigenome editing, secured €4 million in pre-seed funding led by XISTA Science Ventures and Caesar Ventures. The funding includes €2 million in equity and €2 million in non-dilutive grants. The company aims to develop its CADENCE platform for programmable gene expression and advance its first drug candidate.
ProfesorCBD, through its subsidiary Cannabioteacher, has raised 207,000 euros to develop Spain’s first medical cannabis administration device. The funding will support the creation of a medical device designed for medicinal cannabis delivery.
Polish medtech startup BliskoMed announced that entrepreneurs Tomasz and Piotr Karwatka have joined its investor group to support the company’s mission of revolutionizing professional home medical visits.